Welcome: Chemsynlab ,carbohydrate chemistry
Language: Chinese ∷  English

199684-62-3 , gamma-Cyclodextrin dihydrogen phosphate sodium salt , PGCD.Na

199684-62-3 , gamma-Cyclodextrin dihydrogen phosphate sodium salt , PGCD.Na
C48H80Na8O64P8 / 2112.82
MFCD03095446

gamma-Cyclodextrin dihydrogen phosphate sodium salt , PGCD.Na

Gamma-Cyclodextrin Phosphate Sodium Salt (GCDS) is a cyclic oligosaccharide derivative that has recently gained significant attention in the field of biotechnology owing to its unique chemical and physical properties. This paper aims to provide a comprehensive review of GCDS, covering a range of topics from its definition and background to its potential applications in various fields of research and industry.

Definition and Background:

Gamma-Cyclodextrin Phosphate Sodium Salt is a derivative of Cyclodextrin (CD), a cyclic oligosaccharide made up of several glucose units linked together. Gamma-CD, as it is sometimes called, consists of eight glucose molecules, forming a ring-like structure. The difference between Gamma-CD and other CDs is that it contains a phosphate group attached to one of the glucose units. This modification makes Gamma-CD more water-soluble than other CDs and alters its physical and chemical properties.

Physical and Chemical Properties:

Gamma-Cyclodextrin Phosphate Sodium Salt has a white, amorphous solid appearance, and it is soluble in water. The structure of GCDS determines its unique chemical and physical properties. For example, the presence of a phosphate group on the cyclic structure of GCDS makes it more reactive than other cyclodextrins. Additionally, GCDS has a relatively high degree of negative charge, which allows it to bind with cationic compounds.

Synthesis and Characterization:

The synthesis of Gamma-Cyclodextrin Phosphate Sodium Salt is achieved by reacting Gamma-Cyclodextrin with phosphoric acid in the presence of a base. Several methods have been described for the synthesis of GCDS, including direct phosphorylation, phosphorylation via tosylation, and enzymatic phosphorylation. After synthesis, GCDS is usually characterized using various techniques such as NMR, IR, and HPLC.

Analytical Methods:

Analyzing the properties and effectiveness of Gamma-Cyclodextrin Phosphate Sodium Salt in scientific experiments is done using various analytical methods. These methods include chromatography, electrophoresis, and spectrophotometry.

Biological Properties:

Studies have shown that Gamma-Cyclodextrin Phosphate Sodium Salt has anti-inflammatory properties, which make it useful in the treatment of certain diseases. Moreover, it has been demonstrated that GCDS has the ability to form inclusion complexes with various bioactive molecules, these complexes increase the solubility, bioavailability and stability of pharmaceutical agents.

Toxicity and Safety in Scientific Experiments:

The safety of Gamma-Cyclodextrin Phosphate Sodium Salt has been demonstrated through biological studies. In vitro studies have shown that GCDS does not have any cytotoxic effects on mammalian cells at low concentrations. Furthermore, studies have shown that GCDS is non-mutagenic with no genotoxic effects.

Applications in Scientific Experiments:

Gamma-Cyclodextrin Phosphate Sodium Salt has been used in numerous scientific experiments due to its unique properties. Applications include drug delivery to enhance bioavailability, protein stabilization, and encapsulation of bioactive molecules. Additionally, GCDS has also been utilized in chemical separations, where it is used to separate chiral enantiomers.

Current State of Research:

Research on Gamma-Cyclodextrin Phosphate Sodium Salt is ongoing, focusing on its potential to enhance drug delivery, novel applications in chiral separation, and new ways to utilize its anti-inflammatory effects.

Potential Implications in Various Fields of Research and Industry:

Gamma-Cyclodextrin Phosphate Sodium Salt has vast potential applications in pharmaceuticals and materials science. GCDS can be used to make new materials that are more water-soluble, allowing for better manufacturing processes. In addition, it has been shown that GCDS has great potential as a new tool in the field of drug delivery.

Limitations and Future Directions:

Gamma-Cyclodextrin Phosphate Sodium Salt has shown great potential in a wide range of applications, but there are limitations to its use. Future research is needed to investigate new ways to increase the efficiency of its application in various fields, which may include synthesizing improved GCDS derivatives or inventing new methods of synthesis.

Conclusion:

Overall, Gamma-Cyclodextrin Phosphate Sodium Salt shows great potential for use in various fields of science and industry. As research continues, it is anticipated that GCDS will provide new methods for drug delivery, chiral separations, and the creation of new materials.

CAS Number199684-62-3
Product Namegamma-Cyclodextrin phosphate sodium salt
IUPAC Nameoctasodium;[(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,38R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-10,15,20,25,30,35,40-heptakis[[hydroxy(oxido)phosphoryl]oxymethyl]-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-5-yl]methyl hydrogen phosphate
Molecular FormulaC48H80Na8O64P8
Molecular Weight2112.8 g/mol
InChIInChI=1S/C48H88O64P8.8Na/c49-17-25(57)41-97-9(1-89-113(65,66)67)33(17)105-42-26(58)18(50)35(11(98-42)3-91-115(71,72)73)107-44-28(60)20(52)37(13(100-44)5-93-117(77,78)79)109-46-30(62)22(54)39(15(102-46)7-95-119(83,84)85)111-48-32(64)24(56)40(16(104-48)8-96-120(86,87)88)112-47-31(63)23(55)38(14(103-47)6-94-118(80,81)82)110-45-29(61)21(53)36(12(101-45)4-92-116(74,75)76)108-43-27(59)19(51)34(106-41)10(99-43)2-90-114(68,69)70;;;;;;;;/h9-64H,1-8H2,(H2,65,66,67)(H2,68,69,70)(H2,71,72,73)(H2,74,75,76)(H2,77,78,79)(H2,80,81,82)(H2,83,84,85)(H2,86,87,88);;;;;;;;/q;8*+1/p-8/t9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-;;;;;;;;/m1......../s1
InChI KeyOAHSUJOFJLTTTK-KDMCOMQESA-F
SMILESC(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])O)O)OP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Canonical SMILESC(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])O)O)OP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Isomeric SMILESC([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@H](O2)[C@@H]([C@H]9O)O)COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])COP(=O)(O)[O-])O)O)OP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]


INQUIRY

Scan the qr codeClose
the qr code